Upregulation of Notch Signaling and Cell-Differentiation Inhibitory Transcription Factors in Stable Chronic Obstructive Pulmonary Disease Patients
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Notch signaling pathway components are elevated in the lungs of individuals with chronic obstructive pulmonary disease (COPD). These changes may affect lung repair mechanisms in COPD patients.
Area Of Science
- Pulmonary Medicine
- Molecular Biology
- Cell Signaling
Background
- Notch signaling regulates cell differentiation and fate, crucial processes in lung development and homeostasis.
- Dysregulation of cellular processes is implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD).
Purpose Of The Study
- To investigate the transcriptomic and protein expression of Notch pathway components in stable COPD.
- To correlate these alterations with disease severity and potential impacts on lung repair.
Main Methods
- Analysis of bronchial biopsies and lung parenchyma from individuals with varying COPD severity, control smokers, and non-smokers.
- Utilized immunohistochemistry, ELISA, and transcriptome analyses to quantify Notch receptors, ligands, and transcription factors.
Main Results
- Increased expression of Notch4 and HES7 in bronchial lamina propria of severe COPD patients.
- Elevated Notch1 in bronchiolar epithelium of mild/moderate COPD and control smokers.
- Higher Notch2 levels in lung parenchyma of mild/moderate COPD patients.
- Upregulated DLL4 and HES1 mRNA in lung parenchyma of mild/moderate COPD and control smokers.
Conclusions
- The Notch signaling pathway is upregulated in the lungs of patients with stable COPD.
- These molecular changes may contribute to impaired regenerative and reparative responses in the diseased bronchioles and lung parenchyma.
- Further research is warranted to explore therapeutic targeting of the Notch pathway in COPD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Primary Step: The most critical intervention for all COPD patients who smoke.
Benefits: Slows disease...
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.